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Overcoming the metabolic restrictions of hypoxia may allow the progression of 
lower-grade tumors to glioblastoma multiforme. Our findings of up-regulation of HIF-1a 
and its downstream targets VEGF, GLUT-1, and CAIX in higher-grade gliomas support 
this hypothesis. We compared the gene expression profiles of the U-251 malignant 
glioma cell line under normoxic and hypoxic conditions to discover future research 
targets.
Methods
U-251 cells were grown to 75% confluence and exposed to either normoxic or 
hypoxic conditions for 24 hours. RNA was extracted, amplified, and hybridized to a 
cDNA microarray chip containing ~8,800 universal cellular genes. A threefold increase 
in mRNA expression was used as a threshold value for differential expression. Identified 
genes were divided into cell cycle control, stress response, and “newly connected” 
genes.
Results
Hybridization identified 11 hypoxia-induced genes: One involved with cell cycle 
control (CCNG2), six in stress response (IGFBP3, SLC2A3, GSTT2, FOS, DDIT3, 
AKR1C3), and two newly connected genes {Depp, AKAP4). One stress-related gene 
(AKR1C3) encodes for an enzyme that synthesizes progesterone. Of newly connected
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genes, the gene decidual protein induced by progesterone (Depp) showed the highest 
expression (4.2-fold increase).
Conclusion
Possible future targeting for “hypoxic” glioma cells includes the targets for the 
AP-1 transcription factor complex (FOS), as well as blockade of the enzyme AKR1C3 
with nonsteroidal anti-inflammatory drugs. Possible functions of the highly expressed 
gene Depp include tumor vascularization. Future studies will focus on the hypothesis 
that Depp is up-regulated in an autocrine fashion by the AKR1C3 enzyme in U-251 
glioma cells under hypoxic conditions.
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Astrocytomas are the most common primary central nervous system (CNS) 
tumor. Despite decades of research, the median survival after diagnosis of the most 
aggressive astrocytoma, glioblastoma multiforme (GBM) (WHO Grade IV), is still only 
50 weeks (8, 23). GBM can occur as the result of progression from lower-grade 
astrocytomas (i.e., WHO Grade II or III) or can arise de novo (8). It has been suggested 
that a key step in astrocytoma tumorigenesis is the ability to adapt to hypoxic conditions 
(21, 22, 36).
Cells adapt to hypoxic conditions by activating multiple genes that control the 
metabolic switch to glycolysis, enhance oxygen delivery by stimulating angiogenesis, 
and enhance cellular survival (5). In gliomas, several key players have been identified, 
including hypoxia-inducible factor 1 a (HIF-1 a), vascular endothelial growth factor 
(VEGF), and multiple growth factors and other cytokines (2, 5, 8, 9, 22). Although much 
emphasis has been placed on the role of HIF-1 in this context, the role of additional 
mechanisms has not been adequately explored. In this study, we used cDNA 
microarray to identify possible future research targets by comparing the gene 




The malignant glioma cell line U251 was obtained from American Type Culture 
Collection. Cells were grown in Eagle's modified essential medium at 37°C in a
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humidified incubator under 5% C02/95% air. Growth medium was changed twice 
weekly. U-251 cells were grown to 80% confluence and exposed to either normoxic or 
hypoxic conditions for 24 hours. Two cell culture plates per treatment groups were 
processed for RNA extraction.
Hypoxia chamber cell growth studies
For hypoxia experiments, cells were plated on 100-mm tissue culture dishes 
(Becton Dickinson, Franklin Lake, NJ) until they reached 80% confluence. The culture 
medium was changed immediately before the dishes were placed in a GasPak Plus 
anaerobic culture chamber containing hydrogen and a palladium catalyst (GasPak Plus 
Hydrogen-C02 generators, Becton Dickinson). Two palladium catalyst packets are used 
to diminish the oxygen concentration to 1-2%. Cells were treated for 24 hours. At the 
end of 24 hours, no change in media color was noted, indicating physiologic pH values 
between 7 and 8 were maintained throughout the experiment. To minimize the 
degradation of hypoxia-related molecules, the plates were placed in an ice-water bath 
and washed with ice-cold Dulbecco’s phosphate-buffered saline and phosphatase 
inhibitor buffer (6.25 mM NaF, 1.25 mM Na2V0s). Cells were processed for RNA and 
cDNA microarray experiments as described below.
RNA isolation from U-251 cells in culture
Ribosomal nucleic acid (RNA) extraction was accomplished using a commercially 
available extraction kit, following the manufacturer’s recommended protocol (RNeasy 
Midi Kit, Catalog #75142; Qiagen, Valencia, CA). Briefly, cells were lysed in vitro with
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supplied buffer RLT and (3-mercaptoethanol and homogenized. Samples were then 
protein digested with Qiagen Proteinase K and incubated in a 55°C water bath for 20 
minutes. Next, samples were centrifuged at 3000gfor 5 minutes, after which the 
supernatant was kept and the pellet was discarded. Pure (100%) ethanol was added, 
this mixture was loaded into the supplied silica-gel membrane column and centrifuged 
at 3000gfor 5 minutes, and the flow-through was discarded. Supplied buffer RW1 was 
loaded into the column and centrifuged at 3000gfor 5 minutes and the flow-through was 
again discarded. Deoxyribonucleic acid (DNA) was digested on-column by placing 
DNase I (RNase-Free DNase Set, Catalog #79254, Qiagen) directly onto the nucleic 
acid purification silica-gel membrane and letting it stand at room temperature for 15 
minutes. Buffer RW1 was again placed on-column and allowed to stand for 5 minutes 
before it was centrifuged at 3000gfor 5 minutes and the flow-through discarded. 
Supplied buffer RPE was placed on-column and centrifuged at 3000gfor 5 minutes and 
the flow-through was discarded. The buffer RPE rinse was repeated as above once.
The column was then removed and placed into a new test tube. RNase free water was 
placed directly onto the silica-gel membrane and allowed to stand for one minute, 
followed by centrifuging at 3000gfor 5 minutes. The elution (i.e., flow-through) was 
pipetted off and placed back onto the membrane and centrifuged at 3000g for 5 
minutes. Running the elution through the silica-gel membrane a second time decreases 
the total yield but increases the concentration of isolated total RNA. Extracted RNA was 
stored in RNase free water at -80°C.
Hybridization to cDNA expression microarray blots
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RNA was extracted, amplified, and hybridized to a cDNA microarray chip 
containing ~8,800 universal cellular genes by the microarray core facility (Huntsman 
Cancer Institute, University of Utah, Salt Lake City, Utah) (Figure 1). A total of 4 
samples (2 normoxic and 2 hypoxic) were analyzed by hybridizing one normoxic sample 
with one hypoxic sample for a total of two hybridization experiments.
Microarray gene analysis
A threefold increase in mRNA expression was arbitrarily used as a threshold 
value for differential expression (i.e., mRNA expression under hypoxic conditions 
divided by mRNA under normoxic conditions). Each microarray spot contains a unique 
unigene cluster identifier (e.g., Hs.93675). This unigene cluster number was checked 
against an on-line human genome database
(http://informa.bio.caltech.edu/Hs_browser.html) and only those genes that have been 
identified in humans (i.e., hybridized cDNA genes from other species showing mRNA 
up-regulation were not included in analysis) were reported. Finally, genes were divided 
into “cell cycle,” “stress response,” and “newly connected” genes.
RESULTS
Hybridization identified 11 hypoxia-induced genes. One cell cycle control (cyclin 
G2, CCNG2), six stress response [insulin-like growth factor binding protein 3 (IGFBP3); 
solute carrier family 2, member 3 (SLC2A3); glutathione S-transferase, theta 2 
(GSTT2); v-fos Finkel-Biskis-Jinkins (FBJ) murine osteosarcoma viral oncogene 
homolog (V-FOS); DNA damage-inducible transcript 3 (DDIT3), and aldo-keto
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reductase family 1, member C3 (AKR1C3)], and two newly connected genes [decidual 




Glioblastoma multiforme tumorigenesis is governed by alterations of complex 
pathways and cellular programs. Many mechanisms important to potential treatments of 
this cancer remain undiscovered. By using expression microarray on the glioma U-251 
cell line under hypoxic conditions, we have identified 11 potentially new targets for 
future research efforts. Of these, Depp may have a role in GBM angiogenesis. We 
postulate that this protein may be up-regulated in an autocrine fashion by the protein 
AKR1C3.
Up-regulation of the cell cycle gene CCNG2 in hypoxia
The hypoxia-response gene involved with cell cycle control was cyclin G2 
(CCNG2). CCNG2 is part of the cyclin family, which controls the cell cycle by binding 
cyclin-dependent kinases (CDKs) and regulating their activity (Table 1). Unlike classical 
cyclins that promote cell cycle progression, cyclin G2 blocks cell cycle entry. CCNG2 
mRNA levels have been shown to be elevated in Go and decline as cells enter the cell 
cycle, elevating again in late S and G2-M phases (1, 28). The role of CCNG2 gene up- 
regulation in U-251 cells under hypoxic conditions is unclear, but it is probably 
necessary for conservation of cellular energy and ultimate survival.
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Up-regulation of stress genes in hypoxia
Hypoxia-induced stress-related genes included genes encoding for proteins 
promoting cell survival (IGFBP3, SLC2A3, GSTT2, FOS, AKR1C3), as well as genes 
promoting cell death (DDIT3) (Table 1).
Insulin-like growth factor-binding protein 3 (IGFBP3)
Insulin-like growth factor-binding protein 3 (IGFBP3) is located on chromosome 
7p14-p12. Insulin-like growth factors (IGF), their receptors, and their binding proteins 
play key roles in regulating cell proliferation and apoptosis; however, this system 
becomes uncontrolled in cancer (6). IGFBP3 has multiple functions, including acting as 
the major carrying protein for IGF1 and IGF2, modulating IGF bioactivity, directing 
growth inhibitor, and inducing apoptosis (12, 15). Interestingly, IGFBP3 possesses both 
growth-inhibitory and potentiating effects on cells that are independent of IGF action 
mediated through specific /GF£P3-binding receptors located on cell membranes, 
cytosol, and nucleus. In brain tumors, the IGF system plays an important role in 
tumorigenesis, with apoptosis of tumor cells noted in vivo with the treatment of 
antisense-mediated down-regulation of IGF-1 receptors (14). The specific role that 
IGFBP3 may hold in glioma tumorigenesis is unclear, but other researchers have shown 
that IGFBP3 accumulates in human brain tumors (14).
Solute carrier family 2 (facilitated transporter), member 3 (SLC2A3) (aka GLUT3)
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Solute carrier family 2 (facilitated transporter), member 3 (SLC2A3) [also known 
as glucose transporter 3 (GLUT3)] is located on chromosome 12p13.3 and encodes for 
a glucose transport protein. Hypoxia stimulates glucose transport by enhancing the 
function of the glucose transporters GLUT1, GLUT3, and GLUT4 (42). GLUT3 has been 
shown to be localized to the brain (i.e., “brain-type” glucose transporter) (32). Elevated 
GLUT3 levels have been identified in brain tumors (e.g., GBM), with increased levels 
correlating with biologically aggressive tumors (4, 31, 32). These studies provide 
evidence that up-regulation of the “brain-type” glucose transporter is a vital step in 
astrocytoma tumorigenesis.
Glutathione S-transferase, theta-2 (GSTT2)
Glutathione S-transf erase, theta-2 (GSTT2) maps to chromosome 22q11.2. 
Glutathione S-transferase (GST) enzymes conjugate a vast number of substrates to 
glutathione for detoxification and are important in cellular detoxification of reactive 
oxygen metabolites (10, 26). Specifically, the enzyme GSTT2 dehalogenase activity 
toward halogenated compounds (e.g., dichloromethane). Furthermore, cancerous 
tumors expressing high levels of GST are associated with chemotherapy failure and 
poor patient survival (10). In U-251 glioma cell hypoxia, we hypothesize that GSTT2 
protects against hypoxia-induced reactive oxygen metabolites.
V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (V-Fos)
V-Fos FBJ murine osteosarcoma viral oncogene homolog (V-Fos) (also known 
as oncogene FOS) is located on chromosome 14q24.3 and is a major component of the
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activator protein-1 (AP-1) transcription factor complex. The AP-1 transcription factor 
complex regulates a multigenic invasion program, giving tumor cells the ability to invade 
surrounding tissue. Members of the Fos family (c-Fos, FosB, Fra-1, and Fra-2) dimerize 
with Jun proteins (JunB and JunD) to form the AP-1 transcription factor complex (33). 
AP-1 target genes include the invasion proteins in the matrix metalloproteinase family 
(extracellular proteases), as well as CD44 (cell surface hyaluronan-receptor) (33). 
Studies of human brain tumors showed a significant increase in v-fos mRNA in 
malignant tumors (e.g., GBM) when compared with benign tumors (e.g., cerebellar 
astrocytoma) (16, 17), suggesting that v-Fos may be a good molecular marker of 
aggressive brain tumors.
DNA damage-inducible transcript 3 (DDIT3) (aka CHOP)
DNA damage-inducible transcript 3 (DDIT3) [also known as C/EBP-homologous 
protein (CHOP)] is located on chromosome 12q13.1 -q13.2 and is known to up-regulate 
under hypoxic conditions, functioning to induce death by promoting oxidation in the 
stressed endoplasmic reticulum (ER) (3, 7, 27). DDIT3 has been implicated in the injury 
process of the peripheral nervous system and has been shown to induce neuronal 
apoptosis after neurotrophic factor deprivation and ischemia (30, 39, 40). Given the 
above evidence, DDIT3 expression in U-251 cells under hypoxic conditions is probably 
detrimental to cell survival.
Aldo-keto reductase family 1, member C3 (AKR1C3)




IR Author Manuscript 
UU 
IR Author Manuscript
Aldo-keto reductase family 1, member C3 (AKR1C3) [also known as 3 a- 
hydroxysteroid dehydrogenase, Type II or hydroxysteroid (17-beta) dehydrogenase 5] is 
located on chromosome 10p15-p14 (18). The aldo-keto reductase (AKR) superfamily 
catalyzes the conversion of aldehydes and ketones to alcohols by utilizing NADH and/or 
NADPH as a cofactor. Human 3-a-hydroxysteroid dehydrogenase exists in four isoforms 
named AKR1C1-AKR1C4. AKR1C3 is a multifunctional enzyme that possesses 3a-,
3fB-, and 20a-hydroysteroid dehydrogenase, as well as prostaglandin (PG) synthase 
activities, and it catalyzes androgen, estrogen, progestin, and PG metabolism (18, 24, 
34). The functional plasticity of these isoforms highlights their ability to modulate the 
levels of active androgens, estrogens, and progestins (34). Specifically, AKR1C3 
oxidizes 17|3-oestradiol to oestrone, and 20a-hydroxyprogesterone to progesterone 
(34). Anti-inflammatory drugs highly inhibit this enzyme (29). The mRNA transcript of 
AKR1C3 is found in brain, kidney, liver, lung, placenta, and testis (24). The role of 
AKR1C3 up-regulation in U-251 hypoxic cells is unclear. However, we hypothesize that 
the AKR1C3 enzyme may be producing the progesterone necessary to up-regulate the 
“newly connected” gene Depp (Figure 2).
Newly connected hypoxia-induced genes
Decidual protein induced by Progesterone (Depp)
The decidual protein induced by progesterone {Depp) [also known as fasting- 
induced gene (Fig) and fat-specific expressed gene (Fseg)] is located on chromosome
10. Depp was cloned from human tissues and its sequence deposited into a public 
database in 1999 without further characterization. Its first description was in the context
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of embryo implantation into the uterine wall (41). During pregnancy the uterine lining 
(endometrium) prepares for implantation under the influence of progesterone. After 
embryo implantation, the uterine lining is termed the decidua and serves to support the 
embryo throughout gestation. Watanabe et al. (41) identified this protein from 
endometrial stromal cells (ESC) clone cells stimulated with progesterone. In vitro ESC 
experiments showed up-regulation of this protein with progesterone stimulation and 
inhibition of protein expression with the antiprogestin RU486 (41). Therefore, the name 
decidual protein induced by progesterone was given. Depp localizes to the nucleus 
more than the cytoplasm (41). Depp has been shown to be expressed in placenta, 
ovary, kidney, and arterial endothelial cells (35, 41). Studies suggest that Depp affects 
gene expression by activating the Elk-1 transcription factor, as well as by promoting 
tumor vascularization and wound healing (35, 41). The authors hypothesize that Depp 
may be acting as another mechanism by which astrocytomas promote blood vessel 
formation.
AKAP4
A-kinase anchor protein 4 (AKAP4) is located on Xp11.2 and encodes for an 
anchoring protein that tethers a cAMP-dependent protein kinase near its substrate (13). 
AKAP4 is found in the fibrous sheath of sperm flagellum and is involved in sperm 
motility (13). Other protein kinase A-binding proteins that are present in neuronal 
synapses and the hippocampus are involved with melatonin synthesis in the pineal 
gland and are also located near neuronal calcium channels (11, 25, 37, 38). It is unclear 
what role AKAP4 plays in hypoxia.




IR Author Manuscript 
UU 
IR Author Manusc
Hypothesis: AKR1 C3-derived progesterone up-regulates Depp in glioma hypoxia 
On the basis of these findings, we hypothesize that hypoxia induces the up- 
regulation of the enzyme AKR1C3, which increases progesterone production. This 
increase in progesterone cellular levels drives Depp in an autocrine fashion, aiding 
glioma adaptation via increased angiogenesis (Figure 2). This hypothesis is further 
supported by studies showing that astrocytic tumors locally synthesize progesterone 
and that progesterone receptor expression increases with astrocytoma tumor grade, 
with 100% of GBMs exhibiting progesterone receptors (19, 20). We acknowledge that 
this hypothetical model is based on a single glioma cell line, but we are hopeful that 
these initial findings may ultimately lead to new GBM treatment targets.
CONCLUSIONS
Possible future targeting for “hypoxic” glioma cells includes the targets for the 
AP-1 transcription factor complex (FOS) and blockade of the enzyme AKR1C3 with 
nonsteroidal anti-inflammatory drugs. Possible functions of the highly expressed gene 
Depp may include angiogenesis and represent an interesting finding. Future studies will 
focus on the hypothesis that Depp is up-regulated in an autocrine fashion by the 
enzyme AKR1C3 in U-251 glioma cells under hypoxic conditions.
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Figure 1: A-B. Representative microarray glass slide (A) with ~8,800 single-stranded 
DNA molecules attached at fixed locations (spots, enlarged view in B). RNA was 
extracted from normoxic U-251 (control) and hypoxic U-251 (sample) cells and labeled 
with fluorescent dye (green or red, respectively). Extracts are washed over the 
microarray. Gene sequences from the extracts hybridize to their complementary 
sequences in the spots. The dyes enable the amount of sample bound to a spot to be 
measured from the level of fluorescence emitted when excited by a laser. If the RNA 
from the sample population is abundant, the spot will be red; if the RNA from the control 
population is abundant, it will be green; if sample and control bind equally, the spot will 
be yellow; if neither binds, it will appear black. Thus, the relative expression levels of the 
genes in the sample and control populations can be estimated from the fluorescence 
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Figure 2: Hypothetical pathway by which decidual protein induced by progesterone 
(Depp) is up-regulated in an autocrine fashion in U-251 glioma cells under hypoxic 
conditions. This speculative diagram is based on the up-regulation of aldo-keto 
reductase family 1, member 3 (AKR1C3) mRNA and Depp mRNA under hypoxic 
conditions. The function of Depp is largely unknown, but it appears to be a key protein 
in the maturation of the uterine lining after embryo implantation (i.e., decidua), 
suggesting cell proliferative and/or angiogenic role(s).
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Table 1: Hypoxic genes identified in U-251 cells by cDNA microarray. Relative increase
c
c




c Gene Possible role(s) under Relative Unigene
nr




ccr>n CCNG2 Cyclin G2 GO cell arrest 3.3 Hs.79069
rt- "Stress" Response
Insulin-like growth factor Both growth proliferative and
IGFBP3 binding protein 3 










GSTT2 theta 2 reactive oxygen metabolites 3.8 Hs.1581
v-Fos FBJ murine








DDIT3 transcript 3 Promotes apoptosis 3.0 Hs.129913
Pri'nr
0
Aldo-keto reductase family 1, Modulate levels of androgen,
H
AKR1C3 member C3 estrogens and progestins 3.0 Hs.78183
nssncr> Newly Connected GenesO
£■rt-
Decidual protein induced by
DEPP progesterone Angiogenesis 4.3 Hs.93675
AKAP4 A-kinase anchor protein 4 Unclear 3.5 Hs.97633
